Silvia Antonelli is Senior Director of Price, Reimbursement and Access for Italy at Eli Lilly and Company. She has spent more than sixteen years at Lilly, moving from account management and quality improvement into pricing and access. She led price, reimbursement and access for Lilly’s autoimmune portfolio in Italy and worked as a payer strategist at subnational level, launching products in autoimmune disease and migraine. She later represented European payer perspectives on early-stage pipeline assets and business development deals in Lilly’s international new product planning team. Before her current role she was Senior Director for Diabetes and Biomedicine. She has co-authored health economics studies in psoriasis and rheumatoid arthritis, and regularly lectures on market access to students on SDA Bocconi’s MIHMEP master’s programme.
